The Effect of Whole Body Vibration on Muscle Elasticity (WBV)

July 29, 2024 updated by: Gönül Elpeze, Gaziantep Islam Science and Technology University

The Effect of Whole Body Vibration on Pain and Muscle Elasticity in Individuals With Hyperlordosis and Normal Lordosis

This study examined the effect of whole-body vibration on pain and muscle elasticity in individuals with hyperlordosis and normal lordosis.

Flexible ruler for individuals' spinal curvatures (lumbar lordosis); back-lower back pain levels VAS; muscle elasticity Myoton Pro device; Physical functions will be evaluated with the Modified Oswestry low back pain scale.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study examined the effect of whole-body vibration on pain and muscle elasticity in individuals with hyperlordosis and normal lordosis.

Flexible ruler for individuals' spinal curvatures (lumbar lordosis); back-lower back pain levels VAS; muscle elasticity Myoton Pro device; Physical functions will be evaluated with the Modified Oswestry low back pain scale.

The viscoelasticity properties ( tone, stiffness, elasticity) of the Musculus Trapezius and Musculus Pectoralis were assessed with MyotonPro® (Myoton AS, Estonia) during prone position on both sides.

Individuals will be divided into two groups: hyperlordosis and normal lordosis. Whole body vibration will be applied twice a week for six weeks, with a frequency of 30 Hz and an intensity of 2 mm.

A total of 28 females and males (14 individuals for each group) with hyperlordosis (>40°) and normal lordosis participated in the study.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gaziantep, Turkey
        • Gaziantep Islam Science and Technology University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being over 18 years of age,
  • Having pain >5 according to VAS measurement,
  • Having normal lumbar lordosis angle between 30°-40°,
  • Having hyperlordosis angle >40°

Exclusion Criteria:

  • Having Scheurmann kyphosis, ,
  • Having scoliosis (Cobb angle >10°),
  • Having other congenital spine abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: LORDOSİS
30-40
Whole body vibration will be applied while standing with a frequency of 30 Hz and an intensity of 2 mm by vibration machine
Experimental: HYPERLORDOSİS
40<
Whole body vibration will be applied while standing with a frequency of 30 Hz and an intensity of 2 mm by vibration machine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle viscoelastic properties
Time Frame: 6 weeks
muscle stiffness
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: 6 weeks
Visual Analog Scale: between 0 -10 points; 0 (zero) no pain; 5 (five) Moderate pain; 10 (ten) Worst possible Pain
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gonul Elpeze, Gaziantep Islam Science and Technology University Physical Therapy and Rehabilitation Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2023

Primary Completion (Actual)

April 20, 2024

Study Completion (Actual)

June 28, 2024

Study Registration Dates

First Submitted

July 10, 2024

First Submitted That Met QC Criteria

July 23, 2024

First Posted (Actual)

July 26, 2024

Study Record Updates

Last Update Posted (Actual)

July 30, 2024

Last Update Submitted That Met QC Criteria

July 29, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lordosis

Clinical Trials on Whole body vibration

Subscribe